Milestone study finds PSVT impacts patient life between episodes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. MSFT
4. PLTR
5. META
6. JNJ
7. CSCO
8. KTOS
9. NVDA
10. QQQ

Go back to Milestone study finds PSVT impacts patient life between episodes

Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes

August 27, 2026 8:00 AM EDT

MONTREAL and CHARLOTTE, N.C., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced findings from a longitudinal study describing how paroxysmal supraventricular tachycardia (PSVT) affects patients daily lives and quality of life in the periods between episodes. The findings are being presented in a moderated ePoster session titled The Impact of PSVT on Patients Daily Life and QoL in Between Episodes at the... More